Morepen Laboratories Archives - Express Pharma

Morepen Laboratories to expand domestic salesforce by 1,000 as part of formulations growth plan

Morepen Laboratories secures NMPA approval for Loratadine API in China

Impact of COVID-19 on pharma formulation: Bhupendra Pratap Singh Chauhan, CQA Head, Morepen Laboratories

Morepen Labs Q3 revenue up by 29 per cent with 14 per cent jump in Profit Before Tax

RDIF and Morepen Laboratories announce test batch manufacturing of Sputnik V in India

Morepen Group gets $100 million investment from Corinth Group

Bulk drug manufacturers seek support from govt, regulatory authorities

Morepen Labs clocks double-digit growth in its sales and net profit in FY 2019-20

‘R&D continues to be the key driver for sustained growth’—Kushal Suri, Head International Business Development, Morepen Laboratories

Morepen Laboratories reports net sales revenue of Rs 196.60 crore in Q2’FY 2019-20